GlassScriptPhysician profile
Consuelo Sese
NPI 1245306604
$2,614.22
in general payments reported to CMS, 2019-2025
13 companies · $840 in 2025
The $840 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $255 · 2023: $594 · 2024: $924 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,289 · Entertainment: $70.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,288.51 |
| Entertainment | $70.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $606.20 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $574.54 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $324.32 | 2022-2025 | Miebo, Xiidra, Infuse |
| Sun Pharmaceutical Industries INC. | $310.92 | 2022-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $195.28 | 2023-2025 | Acuvue |
| Dompe US, INC. | $132.55 | 2024-2025 | Oxervate |
| Alcon Vision LLC | $126.89 | 2023-2025 | Clareon, Precision7, Precision 1 |
| Coopervision INC. | $98.36 | 2022-2024 | Myday Contact Lens |
| Thea Pharma INC. | $83.23 | 2023-2024 | Iyuzeh |
| Optos, INC. | $70.37 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $49.93 | 2024 | Cirrus Hd-Oct |
| Harrow Eye, LLC | $25.45 | 2024 | Vevye |
| Novartis Pharmaceuticals Corporation | $16.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Consuelo Sese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.